Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-Small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.

Lo Russo G, Moro M, Sommariva M, Cancila V, Boeri M, Centonze G, Ferro S, Ganzinelli M, Gasparini P, Huber V, Milione M, Porcu L, Proto C, Pruneri G, Signorelli D, Sangaletti S, Sfondrini L, Storti C, Tassi E, Bardelli A, Marsoni S, Torri V, Tripodo C, Colombo MP, Anichini A, Rivoltini L, Balsari A, Sozzi G, Garassino M.

Clin Cancer Res. 2018 Sep 11. pii: clincanres.1390.2018. doi: 10.1158/1078-0432.CCR-18-1390. [Epub ahead of print]

PMID:
30206165
2.

Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment.

González JM, Doan J, Gebben DJ, Boeri M, Fishman M.

Pharmacoeconomics. 2018 Aug;36(8):973-986. doi: 10.1007/s40273-018-0640-7.

PMID:
29869777
3.

Physician-Specific Maximum Acceptable Risk in Personalized Medicine: Implications for Medical Decision Making.

Boeri M, McMichael AJ, Kane JPM, O'Neill FA, Kee F.

Med Decis Making. 2018 Jul;38(5):593-600. doi: 10.1177/0272989X18758279. Epub 2018 Apr 3.

PMID:
29611459
4.

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2018 Feb 27;8(1):3965. doi: 10.1038/s41598-018-21279-z.

5.

The STARTEC Decision Support Tool for Better Tradeoffs between Food Safety, Quality, Nutrition, and Costs in Production of Advanced Ready-to-Eat Foods.

Skjerdal T, Gefferth A, Spajic M, Estanga EG, de Cecare A, Vitali S, Pasquali F, Bovo F, Manfreda G, Mancusi R, Trevisiani M, Tessema GT, Fagereng T, Moen LH, Lyshaug L, Koidis A, Delgado-Pando G, Stratakos AC, Boeri M, From C, Syed H, Muccioli M, Mulazzani R, Halbert C.

Biomed Res Int. 2017;2017:6353510. doi: 10.1155/2017/6353510. Epub 2017 Dec 4.

6.

Patients' priorities in selecting chronic lymphocytic leukemia treatments.

Mansfield C, Masaquel A, Sutphin J, Weiss E, Gutierrez M, Wilson J, Boeri M, Li J, Reyes C.

Blood Adv. 2017 Oct 31;1(24):2176-2185. doi: 10.1182/bloodadvances.2017007294. eCollection 2017 Nov 14.

7.

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.

Mensah M, Borzi C, Verri C, Suatoni P, Conte D, Pastorino U, Orazio F, Sozzi G, Boeri M.

J Vis Exp. 2017 Oct 26;(128). doi: 10.3791/56326.

8.

Effects of Cr(VI) on Ca2+-ATPase activity in the earthworm Eisenia andrei.

Boeri M, Oliveri C, Camurati C, Viarengo A, Sforzini S.

Comp Biochem Physiol C Toxicol Pharmacol. 2017 Dec;203:21-28. doi: 10.1016/j.cbpc.2017.10.004. Epub 2017 Oct 12.

PMID:
29032143
9.

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2017 Jul 27;7(1):6689. doi: 10.1038/s41598-017-06912-7. Erratum in: Sci Rep. 2018 Feb 27;8(1):3965.

10.

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.

Pastorino U, Morelli D, Leuzzi G, Gisabella M, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G.

Eur J Cancer. 2017 Jul;79:90-97. doi: 10.1016/j.ejca.2017.03.020. Epub 2017 May 1.

11.

Managing Stigma: Women Drug Users and Recovery Services.

Lee N, Boeri M.

Fusio. 2017 Spring;1(2):65-94.

12.

Inflammatory status and lung function predict mortality in lung cancer screening participants.

Pastorino U, Morelli D, Marchianò A, Sestini S, Suatoni P, Taverna F, Boeri M, Sozzi G, Cantarutti A, Corrao G.

Eur J Cancer Prev. 2018 Jul;27(4):289-295. doi: 10.1097/CEJ.0000000000000342.

13.

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.

Verri C, Borzi C, Holscher T, Dugo M, Devecchi A, Drake K, Sestini S, Suatoni P, Romeo E, Sozzi G, Pastorino U, Boeri M.

J Thorac Oncol. 2017 Jun;12(6):922-931. doi: 10.1016/j.jtho.2017.03.001. Epub 2017 Mar 14.

14.

The Influence of Genotype Information on Psychiatrists' Treatment Recommendations: More Experienced Clinicians Know Better What to Ignore.

McMichael AJ, Boeri M, Rolison JJ, Kane J, O'Neill FA, Scarpa R, Kee F.

Value Health. 2017 Jan;20(1):126-131. doi: 10.1016/j.jval.2016.09.2395. Epub 2016 Nov 4.

15.

Mode of action of Cr(VI) in immunocytes of earthworms: Implications for animal health.

Sforzini S, Moore MN, Mou Z, Boeri M, Banni M, Viarengo A.

Ecotoxicol Environ Saf. 2017 Apr;138:298-308. doi: 10.1016/j.ecoenv.2017.01.013. Epub 2017 Jan 11.

PMID:
28086183
16.

"I Don't Know What Fun Is": Examining the Intersection of Social Capital, Social Networks, and Social Recovery.

Boeri M, Gardner M, Gerken E, Ross M, Wheeler J.

Drugs Alcohol Today. 2016;16(1):95-105.

17.

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature.

Fortunato O, Verri C, Pastorino U, Sozzi G, Boeri M.

Microarrays (Basel). 2016 Jul 5;5(3). pii: E18. doi: 10.3390/microarrays5030018.

18.

Relevance of the bioavailable fraction of DDT and its metabolites in freshwater sediment toxicity: New insight into the mode of action of these chemicals on Dictyostelium discoideum.

Sforzini S, Governa D, Boeri M, Oliveri L, Oldani A, Vago F, Viarengo A, Borrelli R.

Ecotoxicol Environ Saf. 2016 Oct;132:240-9. doi: 10.1016/j.ecoenv.2016.06.013. Epub 2016 Jun 21.

PMID:
27340883
19.

[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].

Sestini S, Boeri M, Marchianò A, Silva M, Calareso G, Galeone C, Sozzi G, Pastorino U.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 1):42-50. doi: 10.19191/EP16.1S1.P042.029. Italian.

20.

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.

Pastorino U, Boffi R, Marchianò A, Sestini S, Munarini E, Calareso G, Boeri M, Pelosi G, Sozzi G, Silva M, Sverzellati N, Galeone C, La Vecchia C, Ghirardi A, Corrao G.

J Thorac Oncol. 2016 May;11(5):693-699. doi: 10.1016/j.jtho.2016.02.011. Epub 2016 Feb 24.

21.

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.

Sestini S, Boeri M, Marchiano A, Pelosi G, Galeone C, Verri C, Suatoni P, Sverzellati N, La Vecchia C, Sozzi G, Pastorino U.

Oncotarget. 2015 Oct 20;6(32):32868-77. doi: 10.18632/oncotarget.5210.

22.

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations.

Hu J, Boeri M, Sozzi G, Liu D, Marchianò A, Roz L, Pelosi G, Gatter K, Pastorino U, Pezzella F.

EBioMedicine. 2015 Jul 8;2(8):831-40. doi: 10.1016/j.ebiom.2015.07.001. eCollection 2015 Aug.

23.

Risk Behaviors Among Suburban Women who Use Methamphetamine: Social Harms and Social Solutions.

Lamonica A, Boeri M.

J Appl Soc Sci (Boulder). 2015 Sep 1;9(2):98-114.

24.

Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.

Boeri M, Sestini S, Fortunato O, Verri C, Suatoni P, Pastorino U, Sozzi G.

Expert Rev Mol Diagn. 2015 Jun;15(6):801-13. doi: 10.1586/14737159.2015.1041377. Epub 2015 Apr 30. Review.

PMID:
25924864
25.

Potential biomarkers for lung cancer screening.

Sozzi G, Boeri M.

Transl Lung Cancer Res. 2014 Jun;3(3):139-48. doi: 10.3978/j.issn.2218-6751.2014.06.04. Review.

26.

Corrigendum to 'Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know'.

Opitz I, Bueno R, Lim E, Pass H, Pastorino U, Boeri M, Rocco G; ESTS Biology Club.

Eur J Cardiothorac Surg. 2015 Jan;47(1):200. doi: 10.1093/ejcts/ezu451. No abstract available.

27.

Addressing inequalities in physical activity participation: implications for public health policy and practice.

Hunter RF, Boeri M, Tully MA, Donnelly P, Kee F.

Prev Med. 2015 Mar;72:64-9. doi: 10.1016/j.ypmed.2014.12.040. Epub 2015 Jan 6.

PMID:
25575799
28.

Conceptualizing Social Recovery: Recovery Routes of Methamphetamine Users.

Boeri M, Gibson D, Boshears P.

J Qual Crim Justice Criminol. 2014 Apr;2(1):5-38.

29.

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.

Fortunato O, Boeri M, Moro M, Verri C, Mensah M, Conte D, Caleca L, Roz L, Pastorino U, Sozzi G.

Cell Death Dis. 2014 Dec 11;5:e1564. doi: 10.1038/cddis.2014.507.

31.

Therapeutic use of microRNAs in lung cancer.

Fortunato O, Boeri M, Verri C, Moro M, Sozzi G.

Biomed Res Int. 2014;2014:756975. doi: 10.1155/2014/756975. Epub 2014 Sep 16. Review.

32.
33.

Effects of PAHs and dioxins on the earthworm Eisenia andrei: a multivariate approach for biomarker interpretation.

Sforzini S, Moore MN, Boeri M, Bencivenga M, Viarengo A.

Environ Pollut. 2015 Jan;196:60-71. doi: 10.1016/j.envpol.2014.09.015. Epub 2014 Oct 8.

PMID:
25305466
34.

YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.

Lorenzetto E, Brenca M, Boeri M, Verri C, Piccinin E, Gasparini P, Facchinetti F, Rossi S, Salvatore G, Massimino M, Sozzi G, Maestro R, Modena P.

Oncotarget. 2014 May 15;5(9):2608-21.

35.

DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected].

Polato F, Rusconi P, Zangrossi S, Morelli F, Boeri M, Musi A, Marchini S, Castiglioni V, Scanziani E, Torri V, Broggini M.

J Natl Cancer Inst. 2014 Apr;106(4):dju053. doi: 10.1093/jnci/dju053. Epub 2014 Mar 20. Erratum in: J Natl Cancer Inst. 2014 Aug;106(8):dju199 doi:10.1093/jnci/dju199.

36.

Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know.

Opitz I, Bueno R, Lim E, Pass H, Pastorino U, Boeri M, Rocco G; ESTS Biology Club.

Eur J Cardiothorac Surg. 2014 Oct;46(4):602-6. doi: 10.1093/ejcts/ezu048. Epub 2014 Mar 12. Review. Erratum in: Eur J Cardiothorac Surg. 2015 Jan;47(1):200.

37.

Assessment of circulating microRNAs in plasma of lung cancer patients.

Fortunato O, Boeri M, Verri C, Conte D, Mensah M, Suatoni P, Pastorino U, Sozzi G.

Molecules. 2014 Mar 10;19(3):3038-54. doi: 10.3390/molecules19033038.

38.

Methamphetamine use among suburban women: implications for nurse practitioners.

Bairan A, Boeri M, Morian J.

J Am Assoc Nurse Pract. 2014 Nov;26(11):620-8. doi: 10.1002/2327-6924.12107. Epub 2014 Feb 10.

39.

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, Marchiano A, Negri E, La Vecchia C, Pastorino U.

J Clin Oncol. 2014 Mar 10;32(8):768-73. doi: 10.1200/JCO.2013.50.4357. Epub 2014 Jan 13. Erratum in: J Clin Oncol. 2014 May 10;32(14):1520.

40.

Immunofluorescence detection and localization of B[a]P and TCDD in earthworm tissues.

Sforzini S, Moore MN, Boeri M, Benfenati E, Colombo A, Viarengo A.

Chemosphere. 2014 Jul;107:282-9. doi: 10.1016/j.chemosphere.2013.12.062. Epub 2014 Jan 10.

PMID:
24412505
41.

Trading off dietary choices, physical exercise and cardiovascular disease risks.

Grisolía JM, Longo A, Boeri M, Hutchinson G, Kee F.

Soc Sci Med. 2013 Sep;93:130-8. doi: 10.1016/j.socscimed.2013.05.031. Epub 2013 Jun 19.

PMID:
23906130
42.
43.

The role of regret minimisation in lifestyle choices affecting the risk of coronary heart disease.

Boeri M, Longo A, Grisolía JM, Hutchinson WG, Kee F.

J Health Econ. 2013 Jan;32(1):253-60. doi: 10.1016/j.jhealeco.2012.10.007. Epub 2012 Oct 26.

PMID:
23228950
45.

Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.

Boeri M, Pastorino U, Sozzi G.

Cancer J. 2012 May-Jun;18(3):268-74. doi: 10.1097/PPO.0b013e318258b743. Review.

PMID:
22647364
46.

Genotoxicity assessment in Eisenia andrei coelomocytes: a study of the induction of DNA damage and micronuclei in earthworms exposed to B[a]P- and TCDD-spiked soils.

Sforzini S, Boeri M, Dagnino A, Oliveri L, Bolognesi C, Viarengo A.

Mutat Res. 2012 Jul 4;746(1):35-41. doi: 10.1016/j.mrgentox.2012.02.011. Epub 2012 Mar 20.

PMID:
22459015
47.

Addiction and sociality: Perspectives from methamphetamine users in suburban USA.

Boshears P, Boeri M, Harbry L.

Addict Res Theory. 2011 Jan 1;19(4):289-301. No abstract available.

48.

Drug use trajectory patterns among older drug users.

Boeri M, Whalen T, Tyndall B, Ballard E.

Subst Abuse Rehabil. 2011 May 1;2011(2):89-102.

49.
50.

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, Sozzi G.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3713-8. doi: 10.1073/pnas.1100048108. Epub 2011 Feb 7.

Supplemental Content

Support Center